Published :
Tables : 53
Figures : 41
Category : Healthcare
No. of Pages : 217
Report Code : HC-U3426
Stromal Vascular Fraction Market is predicted to register a CAGR of over 4.1% during the forecast period 2020 to 2027. Stromal vascular fraction is crucial in regenerative medicine and in treating various chronic disorders. Multiple clinical and pre-clinical investigations have been undertaken for establishing the function of stromal vascular fraction for treating osteoarthritis, rheumatoid arthritis, cartilage regeneration, etc. This method has huge potential in treating orthopaedics due to their homeostatic and immune-modulation properties. Furthermore, the regenerative abilities of SVT are derivations of soluble factors having multiple differentiating abilities with huge potential. Moreover, the SVF injections are intrusive and non-surgical option in orthopaedics for treating musculoskeletal diseases. Such factors shall positively impact the stromal vascular fraction market growth. Stromal Vascular Fraction Market Segmentation: By Product • SVF Aspiration Products • SVF Transfer Products • SVF Isolation Products By Application • Cosmetic Applications • Orthopedic Applications • Soft Tissue Applications • Others By End User • Hospitals • Specialty Clinics • Stem Cell Banks/ Laboratories • Others By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa The market is categorised into product, application, end user and region. The product segment is classified into SVF aspiration products, SCF transfer products, SVF isolation products. The SVF isolation products segment is further divided into enzymatic isolation products, non-enzymatic isolation products, automated POC devices. The application segment is fragmented into cosmetic applications, orthopedic applications, soft tissue applications and others. The end user segment is diversified into hospitals, specialty clinics, stem cell banks and others. Regional Analysis: The North America region is expected to hold the largest stromal vascular fraction market share owing to the rising prevalence of musculoskeletal disorders like osteoarthritis, growing awareness pertaining to stem cell therapy, soaring number of cosmetic surgeries along with growing insistence from clinicians. Furthermore, the increasing investments in research and development of novel technologies coupled with the escalating number of private hospitals across the region. Competitive Landscape: The key market players included are IntelliCell BioSciences Inc., Cytori Therapeutics Inc., Cellular Biomedicine Group Inc., InGeneron Inc., Lifecell Corporation (Allergen PLC), GE Healthcare (Biosafe Group SA), Tissue Genesis Inc. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global stromal vascular fraction market by product, by application, by field end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Stromal Vascular Fraction Market is predicted to register a CAGR of over 4.1% during the forecast period 2020 to 2027.
Stromal vascular fraction is crucial in regenerative medicine and in treating various chronic disorders. Multiple clinical and pre-clinical investigations have been undertaken for establishing the function of stromal vascular fraction for treating osteoarthritis, rheumatoid arthritis, cartilage regeneration, etc. This method has huge potential in treating orthopaedics due to their homeostatic and immune-modulation properties. Furthermore, the regenerative abilities of SVT are derivations of soluble factors having multiple differentiating abilities with huge potential. Moreover, the SVF injections are intrusive and non-surgical option in orthopaedics for treating musculoskeletal diseases. Such factors shall positively impact the stromal vascular fraction market growth. Stromal Vascular Fraction Market Segmentation:
By Product • SVF Aspiration Products • SVF Transfer Products • SVF Isolation Products
By Application • Cosmetic Applications • Orthopedic Applications • Soft Tissue Applications • Others
By End User • Hospitals • Specialty Clinics • Stem Cell Banks/ Laboratories • Others
By Region • North America • Europe • Asia Pacific • Latin America • Middle East & Africa
The market is categorised into product, application, end user and region. The product segment is classified into SVF aspiration products, SCF transfer products, SVF isolation products. The SVF isolation products segment is further divided into enzymatic isolation products, non-enzymatic isolation products, automated POC devices. The application segment is fragmented into cosmetic applications, orthopedic applications, soft tissue applications and others. The end user segment is diversified into hospitals, specialty clinics, stem cell banks and others. Regional Analysis: The North America region is expected to hold the largest stromal vascular fraction market share owing to the rising prevalence of musculoskeletal disorders like osteoarthritis, growing awareness pertaining to stem cell therapy, soaring number of cosmetic surgeries along with growing insistence from clinicians. Furthermore, the increasing investments in research and development of novel technologies coupled with the escalating number of private hospitals across the region. Competitive Landscape: The key market players included are IntelliCell BioSciences Inc., Cytori Therapeutics Inc., Cellular Biomedicine Group Inc., InGeneron Inc., Lifecell Corporation (Allergen PLC), GE Healthcare (Biosafe Group SA), Tissue Genesis Inc. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global stromal vascular fraction market by product, by application, by field end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Stromal Vascular Fraction Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 High Field Stromal Vascular Fraction 7.2 Low to Mid Field Stromal Vascular Fraction 7.3 Very High Field Stromal Vascular Fraction 8. Stromal Vascular Fraction Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Cosmetic Applications 8.2 Orthopedic Applications 8.3 Soft Tissue Applications 8.4 Others 9. Stromal Vascular Fraction Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Hospitals 9.2 Specialty Clinics 9.3 Stem Cell Banks/ Laboratories 9.4 Others 10. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 10.2.1. U.S. 10.2.2. Canada 10.2.3. Mexico 10.2.4 Rest of North America 10.3 Market Size (USD Mn) Forecast for North America 2020-2027 11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Uruguay 11.3.3 Argentina 11.3.4. Rest of Latin America 11.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5 Switzerland 12.2.6. Spain 12.2.7. Russia 12.2.8. Poland 12.2.9. Rest of Western Europe 12.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1 Introduction 13.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 13.2.1 Japan 13.2.2 China 13.2.3 Singapore 13.2.4 Korea 13.2.5 India 13.2.6 Australia and New Zealand 13.2.7 ASEAN 13.2.8 Rest of Asia Pacific 13.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1 Introduction 14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 14.2.1 UAE 14.2.2 South Africa 14.2.3 Egypt 14.2.4 Saudi Arabia 14.2.5 Rest of MEA 14.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 15.1 IntelliCell BioSciences Inc. 15.1.1. Company Overview (HQ, Business Segments, Employee Strength) 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2 Cytori Therapeutics Inc. 15.2.1. Company Overview (HQ, Business Segments, Employee Strength) 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3 Cellular Biomedicine Group Inc. 15.3.1. Company Overview (HQ, Business Segments, Employee Strength) 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4 InGeneron Inc. 15.4.1. Company Overview (HQ, Business Segments, Employee Strength) 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 Lifecell Corporation (Allergen PLC) 15.5.1. Company Overview (HQ, Business Segments, Employee Strength) 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 GE Healthcare (Biosafe Group SA) 15.6.1. Company Overview (HQ, Business Segments, Employee Strength) 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7 Tissue Genesis Inc. 15.7.1. Company Overview (HQ, Business Segments, Employee Strength) 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 16 Impact of COVID-19 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17 Competitive Intelligence and Competitive Matrix 17.1 Competitive Intelligence 17.2 Competitive Matrix 18. Major Deals and Strategic Alliances Analysis 18.1 Joint ventures 18.2 Mergers and acquisitions 18.3 Licensing and partnerships 18.4 Technology Collaborations 18.5 Strategic Divestments 18.6 Market Entry Strategies 19. Relevant Case Studies and Latest News Updates 20. Key Market Takeaway Points from the Market Analysts at FutureWise Market Research
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics